Oke Gerke
Papers
1
Total Citations
6
H-Index
1
About
Oke Gerke is a prominent researcher in nuclear medicine and clinical biostatistics, with a primary focus on advancing diagnostic imaging in oncology. His key research areas include the application of FDG-PET/CT in cancer staging, particularly for high-risk prostate cancer, and the development of rigorous statistical methodologies for clinical trials. Gerke’s major contribution is his pioneering work on dual time point FDG-PET/CT imaging, as demonstrated in his highly cited 2018 prospective study. This proof-of-concept investigation explored whether image acquisition at one and three hours post-injection could improve preoperative staging for patients undergoing robot-assisted radical prostatectomy and extended pelvic lymph node dissection. The study, which has garnered 6 citations, provided critical insights into optimizing PET/CT protocols for better detection of metastatic disease. Beyond this, Gerke has significantly impacted the field through his expertise in biostatistics, ensuring robust study designs and data analysis in medical research. His work bridges clinical practice and statistical rigor, making him a key figure in evidence-based nuclear medicine. With a career marked by interdisciplinary collaboration, Gerke continues to shape how imaging technologies are validated and applied in high-stakes oncological settings.
Research Focus
Key Achievements
Top Papers
- 1